Home › Funds › Hackensack Meridian Health, Inc. › SPY

Hackensack Meridian Health, Inc. position in SPY

STATE STR SPDR S&P 500 ETF T

Hackensack Meridian Health, Inc. reported holding 707,500 shares of SPY (STATE STR SPDR S&P 500 ETF T) in its Q3 2026 13F filing — a position valued at US$539.6M, representing 35.42% of its reported portfolio and ranking #1 among its reported holdings. Hackensack Meridian Health, Inc. has disclosed SPY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)707.50K sh
Reported value held$539.56M
Portfolio Weight35.42%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hackensack Meridian Health, Inc.'s SPY position evolved

Hackensack Meridian Health, Inc. first disclosed a stake in SPY in Q3 2023 at 506,000 shares (US$216.3M). The position peaked in Q3 2026 at 707,500 shares, worth US$539.6M. Across 13 filings, Hackensack Meridian Health, Inc. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 707,500 shares valued at US$539.6M. Notable position changes include a 33% increase in Q2 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 506.00K $216.30M New
Q4 2023 506.00K $240.51M Hold
Q1 2024 506.00K $264.67M Hold
Q2 2024 506.00K $275.38M Hold
Q3 2024 524.00K $300.65M Add
Q4 2024 524.00K $307.11M Hold
Q1 2025 505.50K $282.77M Reduce
Q2 2025 505.50K $312.32M Hold
Q3 2025 505.50K $336.75M Hold
Q4 2025 558.00K $380.51M Add
Q1 2026 531.50K $345.66M Reduce
Q2 2026 707.50K $528.34M Add
Q3 2026 707.50K $539.56M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SPY and 13F data

SPY (STATE STR SPDR S&P 500 ETF T) is a company whose sector is not yet classified in our data. 28 other funds we track also report a position in SPY — the largest reported positions include JPMorgan Chase & Co (US$37.33B), Morgan Stanley (US$24.11B), Bank of America Corp (US$22.98B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SPY

All SPY fund holders →

FAQ

How long has Hackensack Meridian Health, Inc. held SPY?

Hackensack Meridian Health, Inc. has disclosed SPY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Hackensack Meridian Health, Inc.'s current position in SPY?

As of Q3 2026, Hackensack Meridian Health, Inc. holds 707.50K shares of SPY (STATE STR SPDR S&P 500 ETF T), valued at $539.56M, representing 35.42% of its reported portfolio and ranking #1.

Has Hackensack Meridian Health, Inc. been buying or selling SPY?

In the latest 13F filing (Q3 2026), Hackensack Meridian Health, Inc. held unchanged its position in SPY. The position peaked in Q3 2026 at 707.50K shares.

Which other funds hold SPY?

Other major institutional holders of SPY include JPMorgan Chase & Co, Morgan Stanley, Bank of America Corp, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.